Fletcher Payne
2017
In 2017, Fletcher Payne earned a total compensation of $779.2K as Chief Financial Officer at Catalyst Biosciences, a 103% increase compared to previous year.
Compensation breakdown
| Bonus | $152,536 |
|---|---|
| Option Awards | $289,351 |
| Salary | $335,244 |
| Other | $2,092 |
| Total | $779,223 |
Payne received $335.2K in salary, accounting for 43% of the total pay in 2017.
Payne also received $152.5K in bonus, $289.4K in option awards and $2.1K in other compensation.
Rankings
In 2017, Fletcher Payne's compensation ranked 10,142nd out of 14,666 executives tracked by ExecPay. In other words, Payne earned more than 30.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,142 out of 14,666 | 31st |
Division Manufacturing | 3,926 out of 5,772 | 32nd |
Major group Chemicals And Allied Products | 1,379 out of 2,075 | 34th |
Industry group Drugs | 1,119 out of 1,731 | 35th |
Industry Pharmaceutical Preparations | 874 out of 1,333 | 34th |
Source: SEC filing on May 11, 2018.
Payne's colleagues
We found two more compensation records of executives who worked with Fletcher Payne at Catalyst Biosciences in 2017.